Search results
Mar 1, 2024 · This updated Guidance includes strategies to protect people at highest risk of getting seriously ill and provides actionable recommendations for people with common viral respiratory illnesses, including COVID-19, flu, and RSV.
Jul 12, 2024 · Key points. If you have COVID-19 and are more likely to get very sick, medications are available that can reduce your risk of hospitalization and death. Don't delay: Treatments must be started within 5-7 days after you first develop symptoms to be effective.
Jul 25, 2024 · Covid variants surge: People who test positive for Covid don’t need to isolate for five days, according to recent guidance from the CDC.
- Medicines to Prevent Covid-19
- Medicines to Treat Covid-19
- Nirmatrelvir-Ritonavir
- Remdesivir
- Molnupiravir
- For People with Covid-19 Who Are in The Hospital
- Convalescent Plasma
- Medicine That Doesn't Treat Or Prevent Covid-19
Some medicine can help people who are at high risk of serious illness avoid getting sick. The monoclonal antibody pemivibart (Pemgarda) is a prevention medicine. The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems.
Your healthcare professional may suggest certain medicines if you test positive for COVID-19 and are at high risk of serious illness. These medicines keep mild illness from getting worse. They can include nirmatrelvir-ritonavir (Paxlovid), remdesivir (Veklury) or molnupiravir (Lagevrio).
Paxlovid combines two medicines. The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called replicate. The second medicine, called ritonavir, helps slow the breakdown of nirmatrelvir. Paxlovid is approved to treat mild to moderate COVID-19 in people age 12 and older who are at higher risk o...
Remdesivir is a medicine that blocks the virus that causes COVID-19 from spreading in the body. It's used to treat COVID-19 in people age 12 and older. It's given through a needle into a vein, known as intravenously (IV).
The FDA has authorized an antiviral drug called molnupiravir. Molnupiravir treats mild to moderate COVID-19 in adults at higher risk of serious illness who can't take other treatments. The medication is taken by mouth as a pill.
People in the hospital with serious COVID-19 may get remdesivir. Another option is a corticosteroid, such as dexamethasone. That medicine helps lower inflammation. Other medicines include baricitinib (Olumiant) and tocilizumab (Actemra). Baricitinib, a pill, seems to treat COVID-19 as an antiviral medicine and by lowering inflammation. Tocilizumab ...
The FDA also has authorized COVID-19 convalescent plasma therapy with high antibody levels to treat COVID-19. Convalescent plasma comes from blood donated by people who've recovered from COVID-19. It may be used to help people diagnosed with COVID-19 who have weakened immune systems.
Early in the COVID-19 pandemic, no treatments for COVID-19 existed. Researchers tested medicines based in the idea that the drugs could treat or prevent COVID-19. As research has grown, health agencies such as the FDA have authorized or approved the medicines that work and are safe. Researchers also have found out which medicines don't work to trea...
Apr 5, 2024 · COVID-19 can affect people differently. Whether you're caring for yourself or someone else at home, here is some basic information on emergency care, how to stop the spread of the COVID-19 virus and when you can get back to being with others.
Feb 7, 2022 · These medicines, when started within five to 10 days of the onset of symptoms, could help patients who might get very sick from COVID-19 — such as some patients with cancer or chronic lung...
Dec 17, 2021 · Existing monoclonal antibody infusions are an effective treatment for COVID-19, and finding new treatments that work against current and future viral variants is a top priority. The Omicron variant has emerged since this research was completed.
